We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$144B
AUM Growth
+$27.9B
Cap. Flow
+$22.2B
Cap. Flow %
15.4%
Top 10 Hldgs %
31.02%
Holding
7,740
New
680
Increased
3,884
Reduced
2,259
Closed
408

Sector Composition

Rank Sector Weight
1 Technology 8.24%
2 Financials 5.68%
3 Healthcare 5.62%
4 Consumer Discretionary 5.04%
5 Industrials 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMP icon
6201
PUT
Ameriprise Financial
AMP
$49.5B
$30K ﹤0.01%
200
-2,900
-94% -$415K
BGC icon
6202
CALL
BGC Group
BGC
$4.98B
$30K ﹤0.01%
3,888
+2,333
+150% +$17.3K
BWB icon
6203
Bridgewater Bancshares
BWB
$598M
$30K ﹤0.01%
2,262
+1,901
+527% +$24.4K
IEX icon
6204
PUT
IDEX
IEX
$17.3B
$30K ﹤0.01%
+200
New +$29.8K
IHF icon
6205
iShares US Healthcare Providers ETF
IHF
$1.27B
$30K ﹤0.01%
750
-50
-6% -$1.9K
KNOP icon
6206
CALL
KNOT Offshore Partners
KNOP
$368M
$30K ﹤0.01%
+1,400
New +$30.9K
NATR icon
6207
Nature's Sunshine
NATR
$284M
$30K ﹤0.01%
3,409
+2,786
+447% +$24.6K
NCMI icon
6208
CALL
National CineMedia
NCMI
$372M
$30K ﹤0.01%
280
-290
-51% -$25.8K
SOHU
6209
CALL
Sohu.com
SOHU
$383M
$30K ﹤0.01%
1,500
-2,000
-57% -$50.8K
TPVG icon
6210
TriplePoint Venture Growth BDC
TPVG
$210M
$30K ﹤0.01%
2,200
+1,904
+643% +$25.1K
XRAY icon
6211
CALL
Dentsply Sirona
XRAY
$2.37B
$30K ﹤0.01%
800
+700
+700% +$29.1K
CNSL
6212
PUT
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$30K ﹤0.01%
2,300
-600
-21% -$7.42K
SURF
6213
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$30K ﹤0.01%
2,724
+2,192
+412% +$25.7K
NYMX
6214
DELISTED
Nymox Pharmaceutical Corp
NYMX
$30K ﹤0.01%
12,300
+9,929
+419% +$29.3K
ZAGG
6215
CALL
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$30K ﹤0.01%
2,000
-9,800
-83% -$156K
ALRM icon
6216
CALL
Alarm.com
ALRM
$2.82B
$29K ﹤0.01%
+500
New +$25.1K
AXTA icon
6217
CALL
Axalta
AXTA
$8.03B
$29K ﹤0.01%
+1,000
New +$30K
GSBD icon
6218
Goldman Sachs BDC
GSBD
$1.07B
$29K ﹤0.01%
1,300
IYM icon
6219
iShares US Basic Materials ETF
IYM
$1.02B
$29K ﹤0.01%
299
PAGP icon
6220
PUT
Plains GP Holdings
PAGP
$4.92B
$29K ﹤0.01%
1,200
+300
+33% +$7.43K
WBD icon
6221
CALL
Warner Bros
WBD
$67.7B
$29K ﹤0.01%
900
-2,900
-76% -$81.7K
TVRD
6222
PUT
Tvardi Therapeutics
TVRD
$22M
$29K ﹤0.01%
33
-2,425
-99% -$1.75M
PFIE
6223
DELISTED
Profire Energy, Inc
PFIE
$29K ﹤0.01%
8,966
+7,119
+385% +$22.6K
CEA
6224
DELISTED
China Eastern Airlines
CEA
$29K ﹤0.01%
+900
New +$28K
SOGO
6225
PUT
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
$29K ﹤0.01%
3,900
-2,700
-41% -$24.7K

Similar funds

Barclays's Q3 2018 Portfolio in Review

As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.

  • Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
  • Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
  • Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
  • Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
  • Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
  • Barclays opened 680 new positions and closed 408 in Q3 2018.
  • Barclays's portfolio value rose 24% quarter-over-quarter to $144B.

Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.